US › Healthcare

Qilian International Holding Group Limited (BGM)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$0.26+0.43%

Last close · 2026-09-17

Latest quarter · ended 2026-03-31

Revenue

$24.3M

Net profit

$-2.1M

EPS

$-0.03

EPS estimate

$0.00

Net margin

-8.7%

Key statistics

Market cap

$103.3M

Forward P/E

0.0

P/B

0.25

Book value

$1.99

EPS (TTM)

$-0.17

52-week high

$11.79

52-week low

$0.23

50-day MA

$0.29

200-day MA

$1.45

Beta

1.46

Shareholding

Insiders

38.05%

Institutions

0.10%

Largest institutional holders

Fund	Stake
HRT FINANCIAL LLC	0.24%
Geode Capital Management, LLC	0.23%
State Street Corp	0.23%
TWO SIGMA SECURITIES, LLC	0.08%
Susquehanna International Group, LLP	0.08%
XTX Topco Ltd	0.06%
Ground Swell Capital, LLC	0.06%
Tower Research Capital LLC	0.04%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Qilian International Holding Group Limited — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.